JamesDLevineMD
Hematology • Boston, MAMyeloproliferative Disorder Hematology-Oncology
Assistant Professor of Medicine, Beth Israel Deaconess Medical Center
Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Scc913
Boston, MA 02215Phone+1 617-667-9235
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1979 - 1982
University of California (San Francisco)Residency, Internal Medicine, 1977 - 1979
Detroit Medical Center/Wayne State University (Sinai Grace)Internship, Internal Medicine, 1976 - 1977- University of California San Francisco School of MedicineClass of 1976
University of CaliforniaMS, Medical Sciences, 1972 - 1974- University of California, BerkeleyBA, Biochemistry, 1970 - 1972
Certifications & Licensure
CA State Medical License 1977 - Present
MA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) Start of enrollment: 2011 Sep 01
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 236 citationsPD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion VaccineJacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Baldev Vasir, Dimitrios Tzachanis
Journal of Immunotherapy. 2011-06-01 - 122 citationsMUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, Abigail Washington, Ashujit Tagde
Blood. 2017-03-30 - 123 citationsIndividualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.Jacalyn Rosenblatt, Richard Stone, Lynne Uhl, Donna Neuberg, Robin Joyce
Science Translational Medicine. 2016-12-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
